G Formin Plus 5mg/850mg Tablet is a combination oral antidiabetic medication containing Glibenclamide 5mg and Metformin 850mg, designed to improve glycemic control in patients with type 2 diabetes mellitus. Glibenclamide, a sulfonylurea, stimulates pancreatic beta cells to release insulin, thereby reducing blood glucose levels, while Metformin, a biguanide, decreases hepatic glucose production and enhances peripheral glucose uptake and utilization. This dual mechanism addresses both insulin deficiency and insulin resistance, making G Formin Plus effective in managing hyperglycemia when diet, exercise, and monotherapy are insufficient. The tablet is typically prescribed as part of a comprehensive diabetes management plan, including lifestyle modifications. It is important to monitor blood glucose regularly to adjust dosage and minimize the risk of hypoglycemia, a potential side effect primarily due to Glibenclamide. Metformin’s common adverse effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, which often improve with continued use. G Formin Plus should be used cautiously in patients with renal or hepatic impairment, and contraindicated in conditions predisposing to lactic acidosis. Patients should inform their healthcare provider of any other medications or medical conditions before starting therapy to ensure safe and effective use.